These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38034538)

  • 1. Safety and efficacy of canakinumab treatment for undifferentiated autoinflammatory diseases: the data of a retrospective cohort two-centered study.
    Alexeeva E; Shingarova M; Dvoryakovskaya T; Lomakina O; Fetisova A; Isaeva K; Chomakhidze A; Chibisova K; Krekhova E; Kozodaeva A; Savostyanov K; Pushkov A; Zhanin I; Demyanov D; Suspitsin E; Belozerov K; Kostik M
    Front Med (Lausanne); 2023; 10():1257045. PubMed ID: 38034538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X; Tian F; Wu B; Xu T
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canakinumab in colchicine resistant familial Mediterranean fever and other pediatric rheumatic diseases.
    Çakan M; Karadağ ŞG; Ayaz NA
    Turk J Pediatr; 2020; 62(2):167-174. PubMed ID: 32419407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort.
    Salugina SO; Torgashina AV; Borzova EY; Rameev VV; Gorodetsky VR; Fedorov ES; Muravyova NV
    Dokl Biochem Biophys; 2024 Aug; 517(1):214-227. PubMed ID: 38861148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic literature review of efficacy/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.
    Atas N; Eroglu GA; Sodan HN; Ozturk BO; Babaoglu H; Satis H; Karadeniz H; Guler AA; Salman RB; Goker B; Ozturk MA; Haznedaroglu S; Tufan A
    Clin Exp Rheumatol; 2021; 39 Suppl 132(5):30-36. PubMed ID: 34251317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.
    Soriano A; Soriano M; Espinosa G; Manna R; Emmi G; Cantarini L; Hernández-Rodríguez J
    Front Immunol; 2020; 11():865. PubMed ID: 32655539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases.
    Sözeri B; Demir F; Sönmez HE; Karadağ ŞG; Demirkol YK; Doğan ÖA; Doğanay HL; Ayaz NA
    Clin Rheumatol; 2021 Jun; 40(6):2327-2337. PubMed ID: 33165748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States.
    Hur P; Lomax KG; Ionescu-Ittu R; Manceur AM; Xie J; Cammarota J; Gautam R; Sanghera N; Kim N; Grom AA
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):143. PubMed ID: 34521444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.
    De Benedetti F; Gattorno M; Anton J; Ben-Chetrit E; Frenkel J; Hoffman HM; Koné-Paut I; Lachmann HJ; Ozen S; Simon A; Zeft A; Calvo Penades I; Moutschen M; Quartier P; Kasapcopur O; Shcherbina A; Hofer M; Hashkes PJ; Van der Hilst J; Hara R; Bujan-Rivas S; Constantin T; Gul A; Livneh A; Brogan P; Cattalini M; Obici L; Lheritier K; Speziale A; Junge G
    N Engl J Med; 2018 May; 378(20):1908-1919. PubMed ID: 29768139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health data.
    Alexeeva E; Krekhova E; Dvoryakovskaya T; Isaeva K; Chomakhidze A; Chistyakova E; Lomakina O; Denisova R; Mamutova A; Fetisova A; Gautier M; Vankova D; Kriulin I; Saygitov R
    Front Pediatr; 2023; 11():1114207. PubMed ID: 36911042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for reducing inflammation in familial Mediterranean fever.
    Wu B; Xu T; Li Y; Yin X
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010893. PubMed ID: 30338514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever.
    Kuemmerle-Deschner JB; Gautam R; George AT; Raza S; Lomax KG; Hur P
    Rheumatology (Oxford); 2020 Oct; 59(10):2711-2724. PubMed ID: 32533192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.
    Kostik MM; Suspitsin EN; Guseva MN; Levina AS; Kazantseva AY; Sokolenko AP; Imyanitov EN
    Rheumatol Int; 2018 May; 38(5):887-893. PubMed ID: 29500522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases.
    Massaro MG; Caldarelli M; Franza L; Candelli M; Gasbarrini A; Gambassi G; Cianci R; Rigante D
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K; Boura P; Dalekos GN; Garyfallos A; Karokis D; Pikazis D; Settas L; Skarantavos G; Tsitsami E; Sfikakis PP
    J Rheumatol; 2017 Jan; 44(1):102-109. PubMed ID: 28042127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger.
    Brogan PA; Hofer M; Kuemmerle-Deschner JB; Koné-Paut I; Roesler J; Kallinich T; Horneff G; Calvo Penadés I; Sevilla-Perez B; Goffin L; Lauwerys BR; Lachmann HJ; Uziel Y; Wei X; Laxer RM
    Arthritis Rheumatol; 2019 Nov; 71(11):1955-1963. PubMed ID: 31161734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience.
    Demir F; Gürler E; Sözeri B
    Arch Rheumatol; 2022 Sep; 37(3):435-443. PubMed ID: 36589607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.